The Effect of Intrahippocampal Injection of Insulin-like Growth Factor-1 on Morphine-Induced Amnesia in Wistar Rats

Document Type: Original Article


1 Professor, Cellular and Molecular Research Center & Department of Physiology , School of Medicine, Guilan University of Medical Sciences ; Neuroscience Research Center, Guilan University of Medical Sciences, Rasht, Iran

2 M.D., Cellular and Molecular Research Center & Department of Physiology, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran

3 M.Sc., Cellular and Molecular Research Center & Department of Physiology, School of Medicine, Guilan University of Medical Sciences Rasht, Iran


Background: Morphine is wildly used as a painkiller in clinics, but causes several side effects such as hyperalgesia, depression and more notably amnesia. Here, we assumed that insulin-like Growth Factor-1 (IGF-1) as a peptide with widespread distribution of receptors in brain regions, especially hippocampus, might be capable to alleviate morphine-induced amnesia.
Methods: Thirty one male Wistar rats were divided into four groups including: morphine+saline, saline+saline, Morphine+IGF-1 and Saline+IGF-1 groups. The animals were cannulated in hippocampus using stereotaxic apparatus. IGF-1 (5 μg/ 1μL /rat) was intrahippocampally injected 30 minutes prior to morphine (10 mg/kg/i.p) injection, and then rats were trained in step-through passive avoidance task. First Latency time (FLT) to enter and total time spent (TTS) in dark were measured 1.5 and 24 hours later. Control group received the same volume of saline.
Results: The results showed that injection of 10 mg/kg morphine, compared with saline, significantly decreased FLT (p=0.001), but increased TTS (p=0.001) 24 hours after the training. Whereas, administration of IGF-1 compared with morphine, significantly increased FLT (p=0.001), but decreased TTS (p=0.001) assessed 24 hours after the training,
Conclusions: These findings indicate that administration of morphine disturbs passive avoidance learning and memory and injection of IGF-1, 30 minutes before morphine injection, prevents amnesia.


  1. Bohn LM, Gainetdinov RR, Lin FT, Lefkowitz RJ, Caron MG. Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. Nature 2000; 408(6813):720-3.
  2. Benyamin R, Trescot AM, Datta S, Buenaventura R, Adlaka R, Sehgal N, et al. Opioid complications and side effects. Pain Physician 2008; 11(2 Suppl):S105-20.
  3. Antonelli T, Tomasini MC, Fuxe K, Agnati LF, Tanganelli S, Ferraro L. Receptor–receptor interactions as studied with microdialysis. Focus on NTR/D2 interactions in the basal ganglia. J Neural Transm (Vienna) 2007; 114(1):105-13.
  4. Babaei P, Vahdati S, Soltani-Tehrani B. BDNF pretreatment attenuates morphine-induced learning and memory impairment in rats. Caspian Journal of Neurological Sciences 2015; 1(1):12-18.
  5. Ardjmand A, Rezayof A, Zarrindast MR. Involvement of central amygdale NMDA receptor mechanism in morphine state-dependent memory retrieval. Neurosci Res 2011; 69(1):25-31.
  6. Galeotti N, Ghelardini C, Bartolini A. Differential prevention of morphine amnesia by antisense oligodeoxynucleotides directed against various Gi-protein alpha subunits. Br J Pharmacol 2001; 133(2):267-74.
  7. Jafarinejad-Farsangia S, Farazmanda A, Rezayof A, Darbandic N. Proteome analysis of rat hippocampus following morphine-induced amnesia and state-dependent learning. Iran J Pharm Res 2015; 14(2):591-602.
  8. Kumaran D, Maguire EA. The human hippocampus: cognitive maps or relational memory? J Neurosci 2005; 25(31):7254-9.
  9. Elvander-Tottie E, Eriksson TM, Sandin J, Ogren SO. 5-HT (1A) and NMDA receptors interact in the rat medial septum and modulate hippocampal-dependent spatial learning. Hippocampus 2009; 19(12):1187-98.
  10. Lisman JE, Grace AA. The hippocampal-vta loop: controlling the entry of information into long-term memory. Neuron 2005; 46(5):703-13.
  11. Neves G, Cooke SF, Bliss TV. Synaptic plasticity, memory and the hippocampus: a neural network approach to causality. Nat Rev Neurosci 2008; 9(1):65-75.
  12. Wrigley S, Arafa D, Tropea D. Insulin-like growth factor 1: at the crossroads of brain development and aging. Front Cell Neurosci 2017; 11:14.
  13. O'Kusky J, Ye P. Neurodevelopmental effects of insulin-like growth factor signaling. Front Neuroendocrinol 2012; 33(3):230-51.
  14. Adem A, Jossan SS, d'Argy R, Gillberg PG, Nordberg A, Winblad B, et al. Insulin-like growth factor 1 (IGF-1) receptors in the human brain: quantitative autoradiographic localization. Brain Res 1989; 503(2):299-303.
  15. Dyer AH, Vahdatpour C, Sanfeliu A, Tropea D. The role of Insulin-Like Growth Factor 1 (IGF-1) in brain development, maturation and neuroplasticity. Neuroscience 2016; 325:89-99.
  16. De la Monte SM. Intranasal insulin therapy for cognitive impairment and neurodegeneration: current state of the art. Expert Opin Drug Deliv 2013; 10(12):1699-709.
  17. Ogren SO. Evidence for a role of brain serotonergic neurotransmission in avoidance learning. Acta Physiol Scand 1985; 544:1-71.
  18. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. 5th ed. San Diego: Academic Press; 2004. p.21.
  19. Jahanmahin A, Abbasnejad Z, Haghparast A, Ahmadiani A, Ghasemi R. The effect of intrahippocampal insulin injection on scopolamine-induced spatial memory impairment and extracellular signal-regulated kinases alteration. Basic Clin Neurosci 2019; 10(1):23-36.
  20. Zhang L, Fang Y, Lian Y, Chen Y, Wu T, Zheng Y, et al. Brain-derived neurotrophic factor ameliorates learning deficits in a rat model of Alzheimer's disease induced by aβ1-42. PLoS One 2015; 10(4):e0122415.
  21. Malek M, Sarkaki A, Zahedi-Asl S, Farbood Y, Rajaei Z. Effect of intra-hippocampal injection of human recombinant growth hormone on synaptic plasticity in the nucleus basalis magnocellularis-lesioned aged rats. Arq Neuropsiquiatr 2017; 75(7):477-83.
  22. Bianchi E, Menicacci C, Ghelardini C. Dual effect of morphine in long-term social memory in rat. Br J Pharmacol 2013; 168(8):1786-93.
  23. Rezayof A, Darbandi N, Zarrindast MR. Nicotinic acetylcholine receptors of the ventral tegmental area are involved in mediating morphine-state-dependent learning. Neurobiol learn Mem 2008; 90(1):255-60.
  24. Ninković J, Roy S. Role of the mu-opioid receptor in opioid modulation of immune function. Amino Acids 2013; 45(1):9-24.
  25. Meilandt WJ, Barea-Rodriguez E, Harvey SA, Martinez JL Jr. Role of hippocampal CA3 mu-opioid receptors in spatial learning and memory. J Neurosci 2004; 24(12):2953-62.
  26. Tirgar F, Rezayof A, Alijanpour S, Yazdanbakhsh N. Interactive effects of morphine and nicotine on memory function depend on the central amygdala cannabinoid CB1 receptor function in rats. Prog Neuropsychopharmacol Biol Psychiatry 2018; 82:62-8.
  27. Chen XL, Lu G, Gong YX, Zhao LC, Chen J, Chi ZQ, et al. Expression changes of hippocampal energy metabolism enzymes contribute to behavioural abnormalities during chronic morphine treatment. Cell Res 2007; 17(8):689-700.
  28. Bierczynska-Krzysik A, Bonar E, Drabik A, Noga M, Suder P, Dylag T, et al. Rat brain proteome in morphine dependence. Neurochem Int 2006; 49(4):401-6.
  29. Trejo JL, Carro E, Lopez-Lopez C, Torres-Aleman I. Role of serum insulin-like growth factor i in mammalian brain aging. Growth Horm IGF Res 2004; 14(Suppl A):S39-43.
  30. Fernandez AM, Torres-Alemán I. Themany faces of insulin-like peptide signalling in the brain. Nat Rev Neurosci 2012; 13(4):225-39.
  31. Licht T, Goshen I, Avital A, Kreisel T, Zubedat S, Eavri R, et al. Reversible modulations of neuronal plasticity by VEGF. Proc Natl Acad Sci USA 2011; 108(12):5081-6.
  32. Deak F, Sonntag WE. Aging, synaptic dysfunction, and insulin-like growth factor (IGF)-1. J Gerontol A Biol Sci Med Sci 2012; 67(6):611-25.
  33. Lynch CD, Lyons D, Khan A, Bennett SA, Sonntag WE. Insulin-like growth factor-1 selectively increases glucose utilization in brains of aged animals. Endocrinology 2001; 142(1):506-9.
  34. Trejo JL, Llorens-Martín MV, Torres-Alemán I. The effects of exercise on spatial learning and anxiety-like behavior are mediated by an IGF-I-dependent mechanism related to hippocampal neurogenesis. Mol Cell Neurosci 2008; 37(2):402-11.